Assertio Holdings, Inc. Common Stock
ASRTAssertio Holdings, Inc. is a pharmaceutical company focused on developing and commercializing innovative therapies for neurological and other specialized conditions. It provides products that address unmet medical needs, often through drug delivery mechanisms aimed at improving patient outcomes. The company operates in the United States and offers a portfolio of medications targeting areas such as pain management, neurology, and inflammation.
Company News
Law firm Ademi LLP announced investigations into three companies: Via Transportation for possible securities fraud related to inaccurate financial statements and business operations disclosures; Assertio Holdings for potential breaches of fiduciary duty regarding fair pricing for shareholders; and Dominion Energy for similar fiduciary duty violat...
Ademi LLP is investigating Assertio Holdings Inc. for potential breaches of fiduciary duty in its $166.4 million acquisition by Zydus at $23.50 per share. The law firm questions whether the board is fulfilling its fiduciary duties to shareholders, citing concerns about insider benefits and restrictive transaction limitations that may prevent comp...
Law firm Ademi LLP announced investigations into securities fraud claims against Badger Meter, Via Transportation, and Assertio Holdings. The investigation into Badger Meter focuses on potential failure to disclose revenue recognition management amid weakening demand and declining orders. Similar investigations are underway for the other two comp...
A federal class action lawsuit against Spectrum Pharmaceuticals alleges the company misled investors about its cancer treatment drug poziotinib's success, causing significant stock price decline after FDA concerns were revealed.
A federal class action lawsuit alleges Spectrum Pharmaceuticals misled investors about its cancer treatment drug poziotinib, causing significant stock price decline after FDA concerns were revealed.
